HIND
NASDAQ · Pharmaceuticals
Vyome Holdings Inc
$1.62
-0.01 (-0.61%)
Open$1.63
Previous Close$1.63
Day High$1.66
Day Low$1.60
52W High$6.56
52W Low$1.62
Volume—
Avg Volume8.7K
Market Cap12.63M
P/E Ratio—
EPS$-3.51
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+1,080.2% upside
Current
$1.62
$1.62
Target
$19.12
$19.12
$13.94
$19.12 avg
$23.15
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.04M | 3.40M | 5.84M |
| Net Income | -33,323,969 | -98,236,397 | 1.21M |
| Profit Margin | -3,209.8% | -3,049.3% | 20.8% |
| EBITDA | -33,903,700 | -105,497,920 | 1.81M |
| Free Cash Flow | — | — | 575.3K |
| Rev Growth | -69.5% | -69.5% | -9.0% |
| Debt/Equity | — | — | 0.79 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,368.84 | +0.30% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $274.87 | +0.94% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $147.01 | +0.05% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.30 | -1.94% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $62.89 | -0.38% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $79.81 | -2.80% | 12.3 | 32.24B |